Answer
TEPEZZA (teprotumumab) is administered by a healthcare professional as an intravenous infusion via an infusion pump, not a push or bolus, under the supervision of a physician experienced in thyroid eye disease diagnosis and treatment, with appropriate medical support for severe reactions.
Sources for this answer
- TEPEZZA 500 mg powder for concentrate for solution for infusionAmgen Ltd · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked